Insulin-like growth factor binding protein-1 activates integrin-mediated intracellular signaling and migration in oligodendrocytes

Journal of Neurochemistry

Volumn 113, Issue 5, 2010, Pages 1319-1330

  Chesik, Daniel ^a   De Keyser, Jacques ^a,b   Bron, Reinier ^a   Fuhler, Gwenny M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Insulin like growth factor; Multiple sclerosis; Remyelination

Indexed keywords

FOCAL ADHESION KINASE; INTEGRIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; P21 ACTIVATED KINASE; RAC PROTEIN; RAL PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TRANSPORT; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ACTINS; ANIMALS; ASTROCYTES; BLOTTING, WESTERN; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLUORESCENT ANTIBODY TECHNIQUE; FOCAL ADHESION KINASE 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR I; INTEGRINS; OLIGODENDROGLIA; P21-ACTIVATED KINASES; RAC GTP-BINDING PROTEINS; RAL GTP-BINDING PROTEINS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 77951906430     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06703.x     Document Type: Article

References (36)

1. Baron W., Colognato H. Ffrench-Constant C. (2005) Integrin-growth factor interactions as regulators of oligodendroglial development and function. Glia 49, 467 479. (Pubitemid 40353833)
2. Brewer M. T., Stetler G. L., Squires C. H., Thompson R. C., Busby W. H. Clemmons D. R. (1988) Cloning, characterization, and expression of a human insulin-like growth factor binding protein. Biochem. Biophys. Res. Commun. 152, 1289 1297.
3. Carson M. J., Behringer R. R., Brinster R. L. McMorris F. A. (1993) Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. Neuron 10, 729 740. (Pubitemid 23127975)
4. Cascone I., Selimoglu R., Ozdemir C., Del N. E., Yeaman C., White M. Camonis J. (2008) Distinct roles of RalA and RalB in the progression of cytokinesis are supported by distinct RalGEFs. EMBO J. 27, 2375 2387.
5. Cavaille F., Neau E., Vouters M., Bry-Gauillard H., Colombel A., Milliez J. Le B. Y. (2006) IGFBP-1 inhibits EGF mitogenic activity in cultured endometrial stromal cells. Biochem. Biophys. Res. Commun. 345, 754 760. (Pubitemid 43777003)
6. Chakraborty C., Gleeson L. M., McKinnon T. Lala P. K. (2002) Regulation of human trophoblast migration and invasiveness. Can. J. Physiol. Pharmacol. 80, 116 124. (Pubitemid 34258660)
7. Chang A., Tourtellotte W. W., Rudick R. Trapp B. D. (2002) Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N. Engl. J. Med. 346, 165 173. (Pubitemid 34438882)
8. Chesik D. De Keyser J 2010) Progesterone and dexamethasone differentially regulate the IGF-system in glial cells. Neurosci. Lett. 468, 178 182.
9. Chesik D., Kuhl N. M., Wilczak N. De Keyser J. (2004) Enhanced production and proteolytic degradation of insulin-like growth factor binding protein-2 in proliferating rat astrocytes. J. Neurosci. Res. 77, 354 362. (Pubitemid 38970979)
10. Chesik D., De Keyser J. Wilczak N. (2007a) Insulin-like growth factor binding protein-2 as a regulator of IGF actions in CNS: implications in multiple sclerosis. Cytokine Growth Factor Rev. 18, 267 278. (Pubitemid 46891286)
11. Chesik D., Glazenburg L., De Keyser J. Wilczak N. (2007b) Enhanced proliferation of astrocytes from beta(2)-adrenergic receptor knockout mice is influenced by the IGF system. J. Neurochem. 100, 1555 1564. (Pubitemid 46376199)
12. Chesik D., De Keyser J. Wilczak N. (2008) Insulin-like growth factor system regulates oligodendroglial cell behavior: therapeutic potential in CNS. J. Mol. Neurosci. 35, 81 90.
13. Compston A., Zajicek J., Sussman J., Webb A., Hall G., Muir D., Shaw C., Wood A. Scolding N 1997) Glial lineages and myelination in the central nervous system. J. Anat. 190 (Pt 2 161 200. (Pubitemid 27101977)
14. Firth S. M. Baxter R. C. (2002) Cellular actions of the insulin-like growth factor binding proteins. Endocr. Rev. 23, 824 854. (Pubitemid 35454590)
15. Frost R. A. Lang C. H. (1999) Differential effects of insulin-like growth factor I (IGF-I) and IGF-binding protein-1 on protein metabolism in human skeletal muscle cells. Endocrinology 140, 3962 3970.
16. Fuhler G. M., Cadwallader K. A., Knol G. J., Chilvers E. R., Drayer A. L. Vellenga E. (2004) Disturbed granulocyte macrophage-colony stimulating factor priming of phosphatidylinositol 3,4,5-trisphosphate accumulation and Rac activation in fMLP-stimulated neutrophils from patients with myelodysplasia. J. Leukoc. Biol. 76, 254 262. (Pubitemid 38857194)
17. Fuhler G. M., Knol G. J., Drayer A. L. Vellenga E. (2005) Impaired interleukin-8- and GROalpha-induced phosphorylation of extracellular signal-regulated kinase result in decreased migration of neutrophils from patients with myelodysplasia. J. Leukoc. Biol. 77, 257 266. (Pubitemid 40326224)
18. Fuhler G. M., Drayer A. L., Olthof S. G., Schuringa J. J., Coffer P. J. Vellenga E. (2008) Reduced activation of protein kinase B, Rac, and F-actin polymerization contributes to an impairment of stromal cell derived factor-1 induced migration of CD34+ cells from patients with myelodysplasia. Blood 111, 359 368.
19. Gleeson L. M., Chakraborty C., McKinnon T. Lala P. K. (2001) Insulin-like growth factor-binding protein 1 stimulates human trophoblast migration by signaling through alpha 5 beta 1 integrin via mitogen-activated protein Kinase pathway. J. Clin. Endocrinol. Metab. 86, 2484 2493. (Pubitemid 32545696)
20. Gockerman A., Prevette T., Jones J. I. Clemmons D. R. (1995) Insulin-like growth factor (IGF)-binding proteins inhibit the smooth muscle cell migration responses to IGF-I and IGF-II. Endocrinology 136, 4168 4173.
21. Goddard D. R., Berry M. Butt A. M. (1999) In vivo actions of fibroblast growth factor-2 and insulin-like growth factor-I on oligodendrocyte development and myelination in the central nervous system. J. Neurosci. Res. 57, 74 85. (Pubitemid 29293581)
22. Gveric D., Cuzner M. L. Newcombe J. (1999) Insulin-like growth factors and binding proteins in multiple sclerosis plaques. Neuropathol. Appl. Neurobiol. 25, 215 225. (Pubitemid 29313226)
23. Jones J. I., Gockerman A., Busby W. H. Jr., Wright G. Clemmons D. R. (1993) Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence. Proc. Natl Acad. Sci. USA 90, 10553 10557. (Pubitemid 23347080)
24. Kuhl N. M., De K. J., De Vries H. Hoekstra D. (2002) Insulin-like growth factor binding proteins-1 and -2 differentially inhibit rat oligodendrocyte precursor cell survival and differentiation in vitro. J. Neurosci. Res. 69, 207 216. (Pubitemid 34734151)
25. Liu X., Yao D. L. Webster H. (1995) Insulin-like growth factor I treatment reduces clinical deficits and lesion severity in acute demyelinating experimental autoimmune encephalomyelitis. Mult. Scler. 1, 2 9.
26. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M. Lassmann H 1999) A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain 122 (Pt 12 2279 2295.
27. Mason J. L., Ye P., Suzuki K., D'Ercole A. J. Matsushima G. K. (2000) Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination. J. Neurosci. 20, 5703 5708. (Pubitemid 30636897)
28. McMorris F. A. Dubois-Dalcq M. (1988) Insulin-like growth factor I promotes cell proliferation and oligodendroglial commitment in rat glial progenitor cells developing in vitro. J. Neurosci. Res. 21, 199 209. (Pubitemid 19031345)
29. Mozell R. L. McMorris F. A. (1991) Insulin-like growth factor I stimulates oligodendrocyte development and myelination in rat brain aggregate cultures. J. Neurosci. Res. 30, 382 390.
30. Richter-Landsberg C. Heinrich M. (1996) OLN-93: a new permanent oligodendroglia cell line derived from primary rat brain glial cultures. J. Neurosci. Res. 45, 161 173. (Pubitemid 26257317)
31. Siskova Z., Baron W., De Vries H. Hoekstra D. (2006) Fibronectin impedes 'myelin' sheet-directed flow in oligodendrocytes: a role for a beta 1 integrin-mediated PKC signaling pathway in vesicular trafficking. Mol. Cell. Neurosci. 33, 150 159. (Pubitemid 44415490)
32. Suzuki J., Yamazaki Y., Li G., Kaziro Y. Koide H. (2000) Involvement of Ras and Ral in chemotactic migration of skeletal myoblasts. Mol. Cell. Biol. 20, 4658 4665. (Pubitemid 30396113)
33. Wilczak N., Chesik D., Hoekstra D. De Keyser J. (2008) IGF binding protein alterations on periplaque oligodendrocytes in multiple sclerosis: implications for remyelination. Neurochem. Int. 52, 1431 1435.
34. Yao D. L., Liu X., Hudson L. D. Webster H. D. (1995) Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis. Proc. Natl Acad. Sci. USA 92, 6190 6194.
35. Ye P., Carson J. D'Ercole A. J. (1995) In vivo actions of insulin-like growth factor-I (IGF-I) on brain myelination: studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice. J. Neurosci. 15, 7344 7356.
36. Zhou G. L., Tucker D. F., Bae S. S., Bhatheja K., Birnbaum M. J. Field J. (2006) Opposing roles for Akt1 and Akt2 in Rac&Pak signaling and cell migration. J. Biol. Chem. 281, 36443 36453. (Pubitemid 46041378)